tiprankstipranks
Trending News
More News >
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market
Advertisement

Diaceutics (DXRX) Financial Statements

Compare
10 Followers

Diaceutics Financial Overview

Diaceutics's market cap is currently $108.57M. The company's EPS TTM is p0.01; its P/E ratio is ―; Diaceutics is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is p-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 32.16M£ 23.70M£ 19.50M£ 13.94M£ 12.70M
Gross Profit£ 28.27M£ 19.71M£ 14.04M£ 10.57M£ 9.33M
Operating Income£ -2.46M£ -2.72M£ 331.00K£ 313.00K£ -610.00K
EBITDA£ 2.77M£ 2.36M£ 3.61M£ 2.11M£ 178.00K
Net Income£ -1.70M£ -1.75M£ 724.00K£ 561.00K£ 263.00K
Balance Sheet
Cash & Short-Term Investments£ 12.74M£ 16.67M£ 19.84M£ 19.68M£ 25.25M
Total Assets£ 48.62M£ 46.34M£ 48.26M£ 45.01M£ 43.52M
Total Debt£ 1.06M£ 1.21M£ 1.33M£ 1.56M£ 118.00K
Net Debt£ -11.68M£ -15.46M£ -18.51M£ -18.11M£ -25.14M
Total Liabilities£ 8.76M£ 5.56M£ 5.74M£ 4.36M£ 3.28M
Stockholders' Equity£ 39.86M£ 40.79M£ 42.51M£ 40.65M£ 40.24M
Cash Flow
Free Cash Flow£ -3.98M£ -3.54M£ 278.00K£ -5.03M£ -6.04M
Operating Cash Flow£ 651.00K£ 1.31M£ 5.15M£ 570.00K£ 253.00K
Investing Cash Flow£ -4.03M£ -4.21M£ -4.87M£ -5.60M£ -6.29M
Financing Cash Flow£ -64.00K£ -239.00K£ -132.00K£ -270.00K£ 19.61M
Currency in GBP

Diaceutics Earnings and Revenue History

Diaceutics Debt to Assets

Diaceutics Cash Flow

Diaceutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis